Drug:
Reaction: NASOPHARYNGITIS
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26914059 |
US |
50 | 1 |
Dysgeusia, Injection site vesicles, Nasopharyngitis, |
||||
SIBEPRENLIMAB, SPARSENTAN, |
||||
| 202 | 26914066 |
US |
32 | 2 |
Rhinorrhoea, Pyrexia, Ear infection, Illness, Nasopharyngitis, |
||||
SIBEPRENLIMAB, |
||||
| 203 | 26914072 |
US |
||
Dizziness, Fatigue, Disorientation, Nasopharyngitis, |
||||
SIBEPRENLIMAB, |
||||
| 204 | 26914104 |
US |
2 | |
Pyrexia, Fatigue, Nasopharyngitis, Injection site swelling, |
||||
SIBEPRENLIMAB, SPARSENTAN, |
||||
| 205 | 26914113 |
US |
41 | 2 |
Bone pain, Hypersensitivity, Pain, Pyrexia, Cough, Nasopharyngitis, |
||||
SIBEPRENLIMAB, |
||||
| 206 | 26914145 |
US |
1 | |
Nasopharyngitis, |
||||
SIBEPRENLIMAB, |
||||
| 207 | 26914414 |
US |
70 | 2 |
Loss of consciousness, Fall, Dizziness, Back pain, Insomnia, Hypotension, Nasopharyngitis, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 208 | 26914578 |
CA |
31 | |
Hernia, Influenza, Nasopharyngitis, Inappropriate schedule of product administration, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, AMLODIPINE, ALBUTEROL SULFATE, MONTELUKAST, |
||||
| 209 | 26904664 |
US |
83 | 1 |
Nasopharyngitis, Product use in unapproved indication, |
||||
SARILUMAB, |
||||
| 210 | 26904907 |
CA |
33 | 2 |
Pneumonia, Illness, Nasopharyngitis, Skin infection, |
||||
GOLIMUMAB, |
||||
| 211 | 26905266 |
CA |
40 | 2 |
Pemphigus, Muscular weakness, Pericarditis, Intentional product use issue, Rheumatic fever, Helicobacter infection, Migraine, Nasopharyngitis, Drug-induced liver injury, Arthropathy, Injection site reaction, Hypoaesthesia, Blister, Lower respiratory tract infection, Rheumatoid arthritis, Drug ineffective, Exposure during pregnancy, Psoriatic arthropathy, Coeliac disease, Pneumonia, Liver injury, Dizziness, Systemic lupus erythematosus, Joint range of motion decreased, Duodenal ulcer perforation, Epilepsy, Drug intolerance, Live birth, Fatigue, Breast cancer stage III, Off label use, Hepatitis, Lip dry, Contraindicated product administered, Stomatitis, Paraesthesia, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, SECUKINUMAB, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ERGOCALCIFEROL, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, OXYCODONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEFLUNOMIDE, LEFLUNOMIDE, VITAMIN C, GOLD, DESOGESTREL AND ETHINYL ESTRADIOL, |
||||
| 212 | 26905306 |
CA |
1 | |
Cataract, Upper-airway cough syndrome, Cough, Nasopharyngitis, Nasal congestion, Intentional dose omission, |
||||
| 213 | 26905383 |
US |
53 | 2 |
Nasopharyngitis, Oropharyngeal pain, Cough, Pain, Lip swelling, Fatigue, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 214 | 26905680 |
CA |
54 | 2 |
Liver injury, Pyrexia, Flushing, Rash, Contusion, Malaise, Nasopharyngitis, Wheezing, Sleep disorder due to a general medical condition, Condition aggravated, Hepatic steatosis, Urticaria, Hypersensitivity, Pain in extremity, |
||||
MEPOLIZUMAB, IPRATROPIUM BROMIDE AND ALBUTEROL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, TIOTROPIUM BROMIDE, OXYGEN, 0XYGEN, ALBUTEROL SULFATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ORAL SEMAGLUTIDE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, |
||||
| 215 | 26905806 |
US |
54 | |
Nasopharyngitis, Respiratory disorder, Blood glucose increased, |
||||
RESMETIROM, |
||||
| 216 | 26906030 |
US |
91 | 2 |
Hypersensitivity, Aphonia, Nasopharyngitis, Cough, Throat irritation, Drug ineffective, |
||||
SARILUMAB, |
||||
| 217 | 26906056 |
CA |
2 | |
Bronchitis, C-reactive protein, Colitis ulcerative, Drug-induced liver injury, Dyspepsia, Ear infection, Facet joint syndrome, Foot deformity, Frequent bowel movements, Hypersensitivity, Hypoaesthesia, Infection, Injury, Joint dislocation, Loss of personal independence in daily activities, Lower limb fracture, Malaise, Maternal exposure during pregnancy, Migraine, Mobility decreased, Nasopharyngitis, Osteoporosis, Pancreatitis, Porphyria acute, Pruritus, Retinitis, Rheumatic fever, Road traffic accident, Sciatica, Seronegative arthritis, Spondylitis, Swollen joint count increased, Visual impairment, |
||||
MEPOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, APREMILAST, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, BETAMETHASONE DIPROPIONATE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM GLUCONATE, CANDESARTAN, CANDESARTAN, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUTICASONE PROPIONATE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, SARILUMAB, DICLOFENAC SODIUM, LANSOPRAZOLE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MESALAMINE, MINOCYCLINE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, OXYCODONE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ERGOCALCIFEROL, LEFLUNOMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, |
||||
| 218 | 26906147 |
US |
60 | 2 |
Nasopharyngitis, Eructation, Dizziness, Tooth disorder, |
||||
LENALIDOMIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 219 | 26906221 |
CN |
52 | 2 |
Drug-induced liver injury, Abdominal pain, Nausea, Hepatic function abnormal, Abdominal distension, Vomiting, Headache, Asthenia, Gastrooesophageal reflux disease, Dyspepsia, Nasopharyngitis, Pyrexia, |
||||
NILOTINIB, |
||||
| 220 | 26906263 |
CA |
58 | 2 |
Chest discomfort, Drug ineffective, Condition aggravated, Knee arthroplasty, Nasopharyngitis, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, FOLIC ACID, PREDNISONE, UPADACITINIB, |
||||
| 221 | 26906868 |
CA |
40 | 2 |
Pneumonia, Migraine, Depression, Dyspepsia, Systemic lupus erythematosus, Hepatitis, Back injury, Blister, Vomiting, Peripheral venous disease, Hypertension, Malaise, Osteoarthritis, Joint swelling, Coeliac disease, Abdominal distension, Bursitis, Hypercholesterolaemia, Taste disorder, Hypersensitivity, Rheumatic fever, Arthropathy, Contusion, Fibromyalgia, Injury, Dry mouth, Rheumatoid arthritis, Gait inability, Infusion related reaction, Nail disorder, Arthralgia, Dyspnoea, Insomnia, Drug hypersensitivity, Synovitis, Gastrointestinal disorder, Stomatitis, Helicobacter infection, Neck pain, Psoriatic arthropathy, Hypoaesthesia, Sleep disorder, Injection site reaction, Irritable bowel syndrome, Onychomadesis, Duodenal ulcer perforation, Pericarditis, Nasopharyngitis, Hand deformity, Pemphigus, Alopecia, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ETANERCEPT, ETANERCEPT, FOLIC ACID, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, MEPOLIZUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 222 | 26907066 |
CA |
85 | |
Lower respiratory tract infection, Condition aggravated, Nasopharyngitis, Wheezing, Productive cough, Sputum discoloured, Cough, Therapy change, Product availability issue, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CICLESONIDE, LATANOPROSTENE BUNOD, |
||||
| 223 | 26907131 |
JP |
23 | 1 |
Extrasystoles, Stomatitis, Palpitations, Nasopharyngitis, Bronchitis, Abdominal pain upper, |
||||
SIROLIMUS, SIROLIMUS, SIROLIMUS, SIROLIMUS, DESLORATADINE, AMOXICILLIN, |
||||
| 224 | 26907164 |
US |
||
Nasopharyngitis, |
||||
ABEMACICLIB, |
||||
| 225 | 26907184 |
US |
53 | 1 |
Psoriatic arthropathy, Injection site pain, Cough, Pyrexia, Sinusitis, Nasopharyngitis, Drug ineffective, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, ROSUVASTATIN, LOSARTAN, PREDNISONE, |
||||
| 226 | 26907394 |
CA |
2 | |
Pemphigus, Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Pericarditis, Peripheral swelling, Pruritus, Pyrexia, Rash, Rheumatoid arthritis, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Weight increased, Wound, Contraindicated product administered, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DESOXIMETASONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, APREPITANT, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CERTOLIZUMAB PEGOL, ETANERCEPT, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, OXYCODONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, RITUXIMAB, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, TOFACITINIB CITRATE, DESOXIMETASONE, LEFLUNOMIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 227 | 26907460 |
US |
36 | 2 |
Cough, Pulmonary congestion, Pyrexia, Infection, Infective pulmonary exacerbation of cystic fibrosis, Product dose omission issue, Socioeconomic precarity, Nasopharyngitis, |
||||
VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR, LEVOTHYROXINE SODIUM, |
||||
| 228 | 26907838 |
US |
73 | 2 |
Respiratory syncytial virus infection, Cough, Nasal congestion, Nasopharyngitis, Respiratory tract infection, |
||||
DUPILUMAB, |
||||
| 229 | 26908146 |
US |
4 | 1 |
Dermatitis, Nasopharyngitis, Influenza, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 230 | 26908499 |
CA |
44 | 2 |
Liver injury, Vomiting, Therapeutic product effect decreased, Treatment failure, Sinusitis, Type 2 diabetes mellitus, Therapy non-responder, Headache, Swelling, Hypersensitivity, Stomatitis, Rheumatic fever, Swollen joint count increased, Wheezing, Hypertension, Ill-defined disorder, Gastrointestinal disorder, Hypoaesthesia, Impaired healing, Insomnia, General physical health deterioration, Weight increased, Inflammation, Urticaria, Sleep disorder due to general medical condition, insomnia type, Irritable bowel syndrome, Rash, Nasopharyngitis, Helicobacter infection, Sleep disorder, Pyrexia, Blister, Pruritus, |
||||
SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALENDRONATE SODIUM, PANTOPRAZOLE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LEFLUNOMIDE, CALCIUM GLUCONATE, CORTISONE ACETATE, CORTISONE ACETATE, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, VITAMIN C, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALENDRONATE SODIUM, GOLIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 231 | 26908619 |
|||
Nasopharyngitis, |
||||
RUXOLITINIB, |
||||
| 232 | 26908818 |
US |
2 | |
Oedema peripheral, Dysphonia, Nasopharyngitis, Insomnia, Dyspnoea, Vision blurred, Pelvic discomfort, Pollakiuria, Diarrhoea, Rhinorrhoea, Conjunctivitis, |
||||
DUPILUMAB, |
||||
| 233 | 26909210 |
US |
1 | |
Lower respiratory tract infection, Rhinovirus infection, Nasopharyngitis, Dizziness, Off label use, Cough, Ill-defined disorder, |
||||
PEGLOTICASE, PEGLOTICASE, PEGLOTICASE, |
||||
| 234 | 26918766 |
71 | 2 | |
Viral infection, Nasopharyngitis, |
||||
LENALIDOMIDE, |
||||
| 235 | 26903747 |
US |
||
Accidental overdose, Inappropriate schedule of product administration, Nasopharyngitis, |
||||
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 236 | 26904112 |
63 | 1 | |
Respiratory tract congestion, Ill-defined disorder, Cough, Nasopharyngitis, |
||||
LENALIDOMIDE, |
||||
| 237 | 26904211 |
US |
59 | 1 |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 238 | 26913978 |
44 | 1 | |
Influenza, Nasopharyngitis, Myalgia, Skin warm, |
||||
LENACAPAVIR SODIUM, |
||||
| 239 | 26902925 |
US |
50 | 2 |
Nasopharyngitis, Asthma, |
||||
DUPILUMAB, PROGESTERONE, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, DIPHENHYDRAMINE HYDROCHLORIDE, PREDNISONE, CALCIUM ANTACID, CALCIUM CARBONATE, ALBUTEROL SULFATE, AMITRIPTYLINE HYDROCHLORIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 240 | 26903234 |
73 | ||
Feeling abnormal, Lethargy, Asthenia, Weight decreased, Nasopharyngitis, COVID-19, Balance disorder, Food aversion, Nervousness, Adverse event, Decreased appetite, Diarrhoea, Vomiting, |
||||
RESMETIROM, RESMETIROM, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, LOSARTAN, FLUOXETINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LANSOPRAZOLE, LANSOPRAZOLE, ALPRAZOLAM, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, |
||||
| 241 | 26903606 |
US |
89 | 2 |
Nasopharyngitis, |
||||
TIRZEPATIDE, |
||||
| 242 | 26897807 |
US |
32 | 2 |
Nasopharyngitis, Pain, Dry skin, Pruritus, Pigmentation disorder, Upper respiratory tract infection, Loss of personal independence in daily activities, Psoriasis, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALBUTEROL SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, TAPINAROF, |
||||
| 243 | 26897977 |
CA |
60 | |
Colitis ulcerative, Osteoarthritis, Arthralgia, Arthritis viral, Diarrhoea, Influenza, Nasopharyngitis, Inappropriate schedule of product administration, Intentional product use issue, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ROSUVASTATIN, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 244 | 26898307 |
US |
1 | |
Nasopharyngitis, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ROSUVASTATIN, ERGOCALCIFEROL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ENTACAPONE, LINACLOTIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 245 | 26898449 |
CN |
1 | 1 |
Hand-foot-and-mouth disease, Nasopharyngitis, Bacterial infection, |
||||
DUPILUMAB, |
||||
| 246 | 26898732 |
US |
11 | 1 |
Nasopharyngitis, Asthma, |
||||
DUPILUMAB, |
||||
| 247 | 26898981 |
CA |
2 | |
Lower respiratory tract infection, Nasopharyngitis, |
||||
VEDOLIZUMAB, LEVOTHYROXINE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 248 | 26899077 |
CA |
2 | |
Duodenal ulcer perforation, Wound, Stomatitis, Blister, Irritable bowel syndrome, Condition aggravated, Pain, Infection, Ill-defined disorder, Sinusitis, Folliculitis, Rash, Injury, Sleep disorder due to general medical condition, insomnia type, Glossodynia, Pyrexia, Hypersensitivity, Contraindicated product administered, Swelling, Arthropathy, Synovitis, Muscle injury, Nasopharyngitis, Confusional state, Sleep disorder, Pruritus, Rheumatoid arthritis, Pericarditis, Joint swelling, Infusion related reaction, General physical health deterioration, Dyspnoea, Systemic lupus erythematosus, Impaired healing, Peripheral swelling, Contusion, Alopecia, Arthralgia, Insomnia, Lower respiratory tract infection, Fatigue, Pemphigus, Gastrointestinal disorder, Anti-cyclic citrullinated peptide antibody positive, Hand deformity, Hepatic enzyme increased, Weight increased, Discomfort, Abdominal discomfort, Helicobacter infection, |
||||
DICLOFENAC, DICLOFENAC SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, APREPITANT, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CERTOLIZUMAB PEGOL, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, OXYCODONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB CITRATE, LEFLUNOMIDE, DESOGESTREL AND ETHINYL ESTRADIOL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 249 | 26899091 |
CA |
32 | 2 |
Pneumonia, Nasal congestion, Infection, Sinusitis, Sleep disorder due to a general medical condition, Vertigo, Urticaria, Vomiting, Rhinitis, Therapeutic product effect decreased, Nasopharyngitis, Decreased activity, Oropharyngeal pain, Stress, Dyspnoea exertional, Eczema, Feeding disorder, Psoriasis, Dizziness, Full blood count abnormal, Pain, Cough, Diarrhoea, Influenza, Tooth abscess, Ear infection, Drug ineffective, Product administration error, Asthma, Middle insomnia, Abdominal pain, Loss of personal independence in daily activities, Upper-airway cough syndrome, Wheezing, Productive cough, Migraine, Therapeutic response decreased, Blood pressure increased, Eosinophil count abnormal, Bacterial infection, Terminal insomnia, Dyspnoea, Anxiety, Fungal infection, Urinary tract infection, Musculoskeletal chest pain, Restrictive pulmonary disease, Nasal discharge discolouration, Emphysema, Forced expiratory volume decreased, Rales, Malaise, Tachycardia, Heart rate increased, Sleep disorder, Obstructive airways disorder, |
||||
FLUTICASONE PROPIONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMALIZUMAB, |
||||
| 250 | 26899311 |
US |
67 | 2 |
Nasopharyngitis, Arthralgia, |
||||
DUPILUMAB, ALBUTEROL SULFATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, BISOPROLOL FUMARATE, BUPROPION, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, MONTELUKAST SODIUM, MONTELUKAST, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, FAMOTIDINE, PREDNISONE, ROSUVASTATIN CALCIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ERGOCALCIFEROL, |
||||
| 251 | 26899372 |
US |
8 | 2 |
Oropharyngeal blistering, Chills, Asthenia, Fatigue, Pain, Dysmenorrhoea, Headache, Intermenstrual bleeding, Nasopharyngitis, Pharyngitis, Viral upper respiratory tract infection, |
||||
TRIPTORELIN, ERGOCALCIFEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IRON, |
||||
| 252 | 26899510 |
US |
1 | |
Nasopharyngitis, Pyrexia, Somnolence, |
||||
NELARABINE, |
||||
| 253 | 26899763 |
US |
2 | |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 254 | 26899859 |
US |
2 | |
Nasopharyngitis, Pleural effusion, Rash erythematous, Arthralgia, Back pain, Decreased appetite, Weight decreased, Dysgeusia, |
||||
OSIMERTINIB, OSIMERTINIB, |
||||
| 255 | 26899970 |
CA |
2 | |
Pulmonary fibrosis, Duodenal ulcer perforation, Abdominal discomfort, Alopecia, Arthropathy, Asthma, Autoimmune disorder, Blood cholesterol increased, Chest pain, Confusional state, Contraindicated product administered, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Discomfort, Dizziness, Drug ineffective, Drug intolerance, Dyspepsia, Irritable bowel syndrome, Liver injury, Lower limb fracture, Maternal exposure during pregnancy, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Off label use, Pain, Pemphigus, Pericarditis, Pneumonia, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Exposure during pregnancy, Fatigue, Fibromyalgia, Folliculitis, Gait inability, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hypertension, Hypoaesthesia, Impaired healing, Incorrect route of product administration, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Road traffic accident, Sciatica, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wound, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RAMIPRIL, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, VITAMIN C, VITAMIN C, VITAMIN C, TOFACITINIB, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 256 | 26900041 |
US |
11 | 2 |
Nasopharyngitis, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 257 | 26900115 |
US |
2 | |
Nasopharyngitis, |
||||
TRALOKINUMAB-LDRM, |
||||
| 258 | 26900360 |
US |
0 | 2 |
Nasopharyngitis, Vomiting, Peripheral coldness, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 259 | 26900363 |
JP |
||
Nasopharyngitis, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 260 | 26900469 |
US |
1 | 2 |
Nasopharyngitis, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 261 | 26900470 |
US |
1 | |
Nasopharyngitis, Infection, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 262 | 26900471 |
US |
2 | |
Nasopharyngitis, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 263 | 26900528 |
JP |
||
Nasopharyngitis, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 264 | 26900740 |
CA |
60 | 1 |
Back pain, Creatine kinase increased, Decreased appetite, Drooling, Dysgeusia, Epistaxis, Fatigue, Hypertension, Hypoaesthesia, Hypogeusia, Increased tendency to bruise, Lower respiratory tract infection, Myalgia, Nasopharyngitis, Neck pain, Nodule, Peripheral swelling, Rheumatoid nodule, Rhinorrhoea, Upper respiratory tract infection, |
||||
TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, LEFLUNOMIDE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREGABALIN, QUININE, ROSUVASTATIN CALCIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 265 | 26900798 |
JP |
6 | 1 |
Nasopharyngitis, Product administered to patient of inappropriate age, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 266 | 26900871 |
US |
0 | 2 |
Gastrooesophageal reflux disease, Cough, Nasopharyngitis, Nasal congestion, Sneezing, Rhinorrhoea, Insomnia, Decreased appetite, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 267 | 26900906 |
US |
1 | |
Nasopharyngitis, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 268 | 26900924 |
US |
1 | 2 |
Nasopharyngitis, Rhinorrhoea, Product use issue, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 269 | 26900939 |
US |
0 | 2 |
Nasopharyngitis, Sleep disorder, Product administered to patient of inappropriate age, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 270 | 26900940 |
US |
2 | |
Nasopharyngitis, Decreased appetite, Hypotension, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 271 | 26900956 |
US |
0 | 2 |
Nasopharyngitis, Product administered to patient of inappropriate age, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 272 | 26901071 |
US |
2 | |
COVID-19, Nasopharyngitis, Decreased appetite, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 273 | 26901172 |
US |
1 | 2 |
Developmental regression, Nasopharyngitis, Product use issue, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 274 | 26901295 |
JP |
||
Nasopharyngitis, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 275 | 26901297 |
US |
0 | 1 |
Nasopharyngitis, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 276 | 26901323 |
JP |
2 | |
Nasopharyngitis, Herpes simplex test positive, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 277 | 26901465 |
CA |
40 | 2 |
Pemphigus, Muscular weakness, Pericarditis, Intentional product use issue, Rheumatic fever, Helicobacter infection, Migraine, Nasopharyngitis, Drug-induced liver injury, Arthropathy, Injection site reaction, Hypoaesthesia, Blister, Lower respiratory tract infection, Rheumatoid arthritis, Drug ineffective, Exposure during pregnancy, Psoriatic arthropathy, Coeliac disease, Pneumonia, Liver injury, Dizziness, Systemic lupus erythematosus, Joint range of motion decreased, Duodenal ulcer perforation, Epilepsy, Drug intolerance, Live birth, Fatigue, Breast cancer stage III, Off label use, Hepatitis, Lip dry, Contraindicated product administered, Stomatitis, Paraesthesia, |
||||
SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, OXYCODONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEFLUNOMIDE, LEFLUNOMIDE, VITAMIN C, GOLD, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DESOGESTREL AND ETHINYL ESTRADIOL, |
||||
| 278 | 26901498 |
US |
0 | 1 |
Salmonellosis, Nasopharyngitis, Diarrhoea, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 279 | 26901502 |
JP |
9 | 2 |
Nasopharyngitis, Overdose, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 280 | 26901520 |
US |
1 | |
Nasopharyngitis, Product administered to patient of inappropriate age, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, FAMOTIDINE, |
||||
| 281 | 26901574 |
US |
2 | |
Nasopharyngitis, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 282 | 26901632 |
US |
0 | 1 |
Nasopharyngitis, Decreased appetite, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 283 | 26901643 |
US |
2 | |
Nasopharyngitis, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 284 | 26901658 |
US |
2 | |
Nasopharyngitis, Product use issue, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 285 | 26901678 |
US |
0 | 2 |
Nasopharyngitis, Abdominal discomfort, Nasal congestion, Decreased appetite, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 286 | 26902084 |
US |
66 | 2 |
Dysphonia, Nasopharyngitis, Chills, Cough, Nausea, Chest pain, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 287 | 26902100 |
US |
36 | 2 |
Nasopharyngitis, Hypersensitivity, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 288 | 26892041 |
US |
41 | 1 |
Nasopharyngitis, |
||||
SATRALIZUMAB, |
||||
| 289 | 26892280 |
US |
47 | 2 |
Cough, Nasal congestion, Paranasal sinus discomfort, Nasopharyngitis, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, AMOXICILLIN, |
||||
| 290 | 26892360 |
US |
25 | 2 |
Malaise, Nasopharyngitis, Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 291 | 26892402 |
US |
69 | |
Anaphylactic shock, Nasopharyngitis, |
||||
EPTINEZUMAB-JJMR, EPTINEZUMAB-JJMR, |
||||
| 292 | 26892567 |
US |
87 | 1 |
Nasopharyngitis, |
||||
INSULIN GLARGINE, |
||||
| 293 | 26892784 |
US |
2 | |
Lung disorder, Nasopharyngitis, Therapy interrupted, |
||||
BRENSOCATIB, ALBUTEROL SULFATE, ALBUTEROL, METHYLPREDNISOLONE ACETATE, GUAIFENESIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SERTRALINE, TOBRAMYCIN, TOBRAMYCIN SOLUTION, TOBRAMYCIN SULFATE, |
||||
| 294 | 26892859 |
US |
80 | 1 |
Nasopharyngitis, Product use issue, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 295 | 26892948 |
US |
1 | |
Nasopharyngitis, Diarrhoea, |
||||
BEVACIZUMAB-AWWB, |
||||
| 296 | 26893125 |
1 | ||
Nasopharyngitis, Poor quality sleep, |
||||
GIVINOSTAT, |
||||
| 297 | 26893339 |
US |
74 | |
Palpitations, Abdominal pain upper, Headache, Cough, Abdominal discomfort, Feeling abnormal, Overdose, Nasopharyngitis, |
||||
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 298 | 26893584 |
US |
40 | 1 |
Fatigue, Muscular weakness, Back pain, Oedema, Arthralgia, Pain in extremity, Cataract, End stage renal disease, Autoimmune disorder, Injection site discomfort, Skin striae, Injection site bruising, Nasopharyngitis, Vision blurred, Myalgia, Energy increased, Insomnia, Epistaxis, Blood pressure increased, Intraocular pressure test abnormal, |
||||
PREDNISONE, AMLODIPINE BESYLATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CARVEDILOL, FAMOTIDINE, HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TORSEMIDE, |
||||
| 299 | 26894126 |
US |
1 | |
Fall, Weight loss poor, Nasopharyngitis, Muscle atrophy, Fatigue, Depression, Asthenia, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, APALUTAMIDE, |
||||
| 300 | 26894429 |
CA |
65 | 2 |
Adjustment disorder, Affect lability, Angina pectoris, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Product use issue, Psoriasis, Pyrexia, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Sinusitis, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, |
||||
LISINOPRIL, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, RAMIPRIL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30